Literature DB >> 23396361

Site-specific activation of AKT protects cells from death induced by glucose deprivation.

M Gao1, J Liang2, Y Lu2, H Guo2, P German3, S Bai3, E Jonasch3, X Yang4, G B Mills2, Z Ding2.   

Abstract

The serine/threonine kinase AKT is a key mediator of cancer cell survival. We demonstrate that transient glucose deprivation modestly induces AKT phosphorylation at both Thr308 and Ser473. In contrast, prolonged glucose deprivation induces selective AKTThr308 phosphorylation and phosphorylation of a distinct subset of AKT downstream targets leading to cell survival under metabolic stress. Glucose-deprivation-induced AKTThr308 phosphorylation is dependent on PDK1 and PI3K but not EGF receptor or IGF1R. Prolonged glucose deprivation induces the formation of a complex of AKT, PDK1 and the GRP78 chaperone protein, directing phosphorylation of AKTThr308 but not AKTSer473. Our results reveal a novel mechanism of AKT activation under prolonged glucose deprivation that protects cells from metabolic stress. The selective activation of AKTThr308 phosphorylation that occurs during prolonged nutrient deprivation may provide an unexpected opportunity for the development and implementation of drugs targeting cell metabolism and aberrant AKT signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23396361      PMCID: PMC3874430          DOI: 10.1038/onc.2013.2

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

Review 1.  Understanding resistance to EGFR inhibitors-impact on future treatment strategies.

Authors:  Deric L Wheeler; Emily F Dunn; Paul M Harari
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

2.  The critical role of GRP78 in physiologic and pathologic stress.

Authors:  Kyle T Pfaffenbach; Amy S Lee
Journal:  Curr Opin Cell Biol       Date:  2010-10-21       Impact factor: 8.382

3.  MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.

Authors:  Hiroshi Hirai; Hiroshi Sootome; Yoko Nakatsuru; Katsuyoshi Miyama; Shunsuke Taguchi; Kyoko Tsujioka; Yoko Ueno; Harold Hatch; Pradip K Majumder; Bo-Sheng Pan; Hidehito Kotani
Journal:  Mol Cancer Ther       Date:  2010-06-22       Impact factor: 6.261

4.  Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation.

Authors:  Kajsa Ericson; Christine Gan; Ian Cheong; Carlo Rago; Yardena Samuels; Victor E Velculescu; Kenneth W Kinzler; David L Huso; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-20       Impact factor: 11.205

5.  Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase.

Authors:  Zhiyong Ding; Jiyong Liang; Jin Li; Yiling Lu; Vathsala Ariyaratna; Zhimin Lu; Michael A Davies; John K Westwick; Gordon B Mills
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

6.  The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R.

Authors:  Diansheng Zhong; Li Xiong; Tongrui Liu; Xiuju Liu; Xiangguo Liu; Jing Chen; Shi-Yong Sun; Fadlo R Khuri; Yaping Zong; Qinghua Zhou; Wei Zhou
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

7.  Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.

Authors:  Christina Gewinner; Zhigang C Wang; Andrea Richardson; Julie Teruya-Feldstein; Dariush Etemadmoghadam; David Bowtell; Jordi Barretina; William M Lin; Lucia Rameh; Leonardo Salmena; Pier Paolo Pandolfi; Lewis C Cantley
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 9.  Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.

Authors:  Shomit Sengupta; Timothy R Peterson; David M Sabatini
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

10.  Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.

Authors:  Ayaz Najafov; Eeva M Sommer; Jeffrey M Axten; M Phillip Deyoung; Dario R Alessi
Journal:  Biochem J       Date:  2011-01-15       Impact factor: 3.857

View more
  30 in total

1.  Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth.

Authors:  Saverio Marchi; Mariangela Corricelli; Alessio Branchini; Veronica Angela Maria Vitto; Sonia Missiroli; Giampaolo Morciano; Mariasole Perrone; Mattia Ferrarese; Carlotta Giorgi; Mirko Pinotti; Lorenzo Galluzzi; Guido Kroemer; Paolo Pinton
Journal:  EMBO J       Date:  2018-11-30       Impact factor: 11.598

Review 2.  The PI3K pathway in B cell metabolism.

Authors:  Julia Jellusova; Robert C Rickert
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-08-05       Impact factor: 8.250

3.  The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism.

Authors:  F Marampon; C Antinozzi; C Corinaldesi; G B Vannelli; E Sarchielli; S Migliaccio; L Di Luigi; A Lenzi; C Crescioli
Journal:  Endocrine       Date:  2017-08-07       Impact factor: 3.633

4.  Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.

Authors:  Jianjun Han; Lu Zhang; Hui Guo; Weiya Z Wysham; Dario R Roque; Adam K Willson; Xiugui Sheng; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2015-06-30       Impact factor: 5.482

5.  AMPK Modulates the Metabolic Adaptation of C6 Glioma Cells in Glucose-Deprived Conditions without Affecting Glutamate Transport.

Authors:  Inês Belo do Nascimento; Marie Verfaillie; Gamze Ates; Pauline Beckers; Virginie Joris; Nathalie Desmet; Ann Massie; Emmanuel Hermans
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

Review 6.  The PI3K/AKT Pathway and Renal Cell Carcinoma.

Authors:  Huifang Guo; Peter German; Shanshan Bai; Sean Barnes; Wei Guo; Xiangjie Qi; Hongxiang Lou; Jiyong Liang; Eric Jonasch; Gordon B Mills; Zhiyong Ding
Journal:  J Genet Genomics       Date:  2015-03-19       Impact factor: 4.275

7.  Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.

Authors:  Alden C Klarer; Julie O'Neal; Yoannis Imbert-Fernandez; Amy Clem; Steve R Ellis; Jennifer Clark; Brian Clem; Jason Chesney; Sucheta Telang
Journal:  Cancer Metab       Date:  2014-01-23

8.  Essential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicity.

Authors:  F Rizvi; S Shukla; P Kakkar
Journal:  Cell Death Dis       Date:  2014-03-27       Impact factor: 8.469

9.  Shrewd AKT regulation to survive.

Authors:  Moez Dawood; Gordon B Mills; Zhiyong Ding
Journal:  Oncoscience       Date:  2014-03-17

10.  Activation of Akt protects cancer cells from growth inhibition induced by PKM2 knockdown.

Authors:  Xiaodong Qin; Yuping Du; Xing Chen; Wuyan Li; Jinghong Zhang; Jinbo Yang
Journal:  Cell Biosci       Date:  2014-04-15       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.